Skip to main content
Premium Trial:

Request an Annual Quote

NIDDK Announces Proteomics/Metabolomics Project in Type 2 Diabetes

NEW YORK, March 19 (GenomeWeb News) - The National Institute of Diabetes and Digestive and Kidney Diseases announced today that it will commit $1 million in FY 2005 to fund projects devoted to using proteomic and metabolomic techniques to develop a diagnostic for type 2 diabetes.


Applicants can request funding for two years under the R21 mechanism, followed by three years under the R33 mechanism. The application receipt date for this PAR is July 20, 2004.


In addition to funding, the NIDDK will provide to investigators plasma from diverse individuals for use in validation experiments. Plasma from three types of patients will be provided: those who have been diagnosed with type 2 diabetes; those who have impaired glucose tolerance, and those who have normal glucose tolerance.


The newest PAR is one of several that the NIDDK has issued over the past couple of years inviting investigators to apply proteomics to the study of diabetes.


The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.